Serentil
| Generic Name: | mesoridazine |
| Company: | Novartis |
| Country: | USA |
| |
 |
Description: |
Serentil (mesoridazine besylate), the besylate salt of a metabolite of thioridazine, is a
phenothiazine tranquilizer. |
| |
| Indications: | Serentil (mesoridazine besylate) is indicated for the management of schizophrenic patients who fail to respond adequately to treatment with other antipsychotic drugs.
Due to the risk of significant, potentially life-threatening, proarrhythmic effects with Serentil treatment, Serentil should be used only in patients who have failed to respond adequately to treatment with appropriate courses of other antipsychotic drugs, either because of insufficient effectiveness or the inability to achieve an effective dose due to intolerable adverse effects from those drugs.
Consequently, before initiating treatment with Serentil, it is strongly recommended that a patient be given at least two trials, each with a different antipsychotic drug product at an adequate dose, and for an adequate duration.
Revised April 2009 |
| |
| |
| |
|
|
|
|
Additional Information
Medications for
Mental Illness
Your Child
and Medications
Bipolar
Disorder
Schizophrenia
Guide
Depression
|
